Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-07-29 to 2025-07-30
Current total value of award: $502.17
Description: 4568925691!CLONAZEPAM 0.5 MG ODT UD 60S